ArticleJournal of autism and developmental disorders2026
Perspectives of South Korean Parents Toward Psychotropic Medication Use Among Autistic Individuals.
Article in Journal of autism and developmental disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study aimed to understand the status of psychotropic medication use among autistic individuals and how South Korean parents perceive its effects and the associated communication processes. This study involved three research questions investigating the following: general prescription trends of psychotropic medication use among autistic individuals, psychotropic medication use and its effects, and the communication of psychotropic medication use with stakeholders. This study employed a qualitative design and involved individual interviews with 19 parents of autistic individuals. To be included in the study, participants were required to have a child with autism over 18 years of age, currently receiving psychotropic medication. Constant comparative analysis and emergent coding were used to analyze the data. The general prescription trends of psychotropic medication use were grouped according to age based on the initiation of psychotropic medication use, reasons for psychotropic medication use, dose of psychotropic medication use, and experience of psychiatric hospitalization. Overall, parents were skeptical of the effects of psychotropic medications, leading to non-adherence to the prescribed psychotropic medications. Finally, there was a lack of communication among psychiatrists, autistic adults, and other professionals regarding psychotropic medication use. Future practices are warranted to develop educational programs on medication use, including foundational knowledge on medications, correct dosages, and strategies for managing side effects. Furthermore, ongoing communication among stakeholders should be guaranteed based on team approaches while prioritizing the voices of autistic individuals.
Indexed as
Identifiers
40237852What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.